Announcements: CDC Symposium on Hepatitis C Laboratory Testing and Surveillance --- December 1--2, 2011
The Food and Drug Administration recently approved several highly efficacious drugs for treating persons infected with hepatitis C, serving as an additional impetus for improving efforts to screen for hepatitis C virus (HCV) infection. On December 1--2, 2011, CDC's Division of Viral Hepatitis will host a symposium titled, Identification, Screening, and Surveillance of HCV Infections in the Era of Improved Therapy for Hepatitis C, where international experts will present their latest perspectives and findings regarding HCV screening and surveillance, and roundtable discussions will be held to promote an exchange of ideas. The symposium will take place at CDC's Tom Harkin Global Communication Center, 1600 Clifton Road, Atlanta, GA 30333.
Registration is free. Those interested in attending should register online at http://www.cdc.gov/hepatitis/hcvsymposium2011/registration.htm. Program information, including a schedule of events and list of presenters, is available at http://www.cdc.gov/hepatitis/hcvsymposium2011/program.htm.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.